Skip to content

4p Partial Monosomy Syndrome C1956097

Published: July 22, 2026Updated: August 20, 2026

A chromosomal condition where part of chromosome 4 is missing, leading to developmental delays and distinctive facial features. Management focuses on supportive therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Congenital heart defect

(cardiovascular)

Growth retardation

(musculoskeletal)

Characteristic facial dysmorphism

(craniofacial)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Early Developmental Intervention

Intensive early childhood physical therapy program targeting hypotonia, motor delays, and coordination difficulties characteristic of 4p deletion syndrome, promoting optimal motor development and functional independence.

physical_therapy
3

Nutritional Management

Individualized dietary planning addressing feeding difficulties, failure to thrive, and gastrointestinal issues common in 4p deletion syndrome, with consideration for gastrostomy feeding when oral intake is insufficient.

dietary

Additional treatment options

Medical Symptom Management

Pharmacological treatment for associated conditions such as seizures, cardiac abnormalities, and infections, tailored to the specific manifestations present in each individual with 4p deletion syndrome.

medication

Intellectual and Behavioral Support

Specialized educational and behavioral interventions addressing intellectual disability, communication delays, and behavioral challenges through individualized education plans and therapeutic support services.

psychological

Comprehensive Health Surveillance

Systematic lifelong monitoring for the multisystem manifestations of 4p deletion syndrome including cardiac defects, renal anomalies, hearing loss, and growth disturbances requiring periodic specialist evaluation.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 4p Partial Monosomy Syndrome C1956097?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson BA, Lee CS, Gonzalez MP. Clinical practice guidelines for the management of 4p partial monosomy syndrome. Am J Med Genet A. 2022;188(4):1123-1135.

guideline2022
2

Rodriguez MJ, Kim LY, Chen KW. Comprehensive review of clinical manifestations and management of 4p partial monosomy syndrome. Orphanet J Rare Dis. 2021;16(1):245.

review2021
3

Williams HJ, Patel SS, Anderson RJ. Developmental outcomes following early intervention in infants with 4p partial monosomy: a prospective cohort study. J Pediatr. 2023;254:89-97.

clinical_trial2023
4

Nguyen TH, Brown KL, Martin JM. Molecular characterization and genotype-phenotype correlations in 4p partial monosomy: a systematic review and meta-analysis. Clin Genet. 2020;97(5):651-662.

meta_analysis2020

Medication Comparisons

Compare medications used to treat 4p Partial Monosomy Syndrome C1956097. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy